Low serum creatinine is associated with type 2 diabetes in morbidly obese women and men: A cross-sectional study

BMC Endocrine Disorders

Volumn 10, Issue , 2010, Pages

  Hjelmesæth, Jøran ^a   Røislien, Jo ^a,b   Nordstrand, Njord ^a   Hofsø, Dag ^a   Hager, Helle ^a   Hartmann, Anders ^c  

^a VESTFOLD HOSPITAL TRUST   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; MAGNESIUM;

AGE DISTRIBUTION; ALBUMINURIA; ARTICLE; CAUCASIAN; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FAMILY HISTORY; FEMALE; GLOMERULUS FILTRATION RATE; HIGH RISK POPULATION; HUMAN; HYPERTENSION; INSULIN RESISTANCE; MAGNESIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MORBID OBESITY; NON INSULIN DEPENDENT DIABETES MELLITUS; SEX DIFFERENCE; SMOKING HABIT; WAIST HIP RATIO;

EID: 77950874499     PISSN: None     EISSN: 14726823     Source Type: Journal    
DOI: 10.1186/1472-6823-10-6     Document Type: Article

References (35)

1. Haffner SM, Stern MP, Dunn J, Mobley M, Blackwell J, Bergman RN. Diminished insulin sensitivity and increased insulin response in nonobese, nondiabetic Mexican Americans. Metabolism: Clinical and Experimental 1990, 39:842-847.
2. Hofso D, Jenssen T, Bollerslev J, Roislien J, Hager H, Hjelmesaeth J. Anthropometric characteristics and type 2 diabetes in extremely obese Caucasian subjects: a cross-sectional study. Diabetes Research and Clinical Practice 2009, 86:e9-11. 10.1016/j.diabres.2009.06.016, 19608292.
3. Ferrannini E, Smith JD, Cobelli C, Toffolo G, Pilo A, DeFronzo RA. Effect of insulin on the distribution and disposition of glucose in man. Journal of Clinical Investigation 1985, 76:357-364. 10.1172/JCI111969, 423783, 3894421.
4. Volpi E, Nazemi R, Fujita S. Muscle tissue changes with aging. Current Opinion in Clinical Nutrition & Metabolic Care 2004, 7:405-410.
5. Atlantis E, Martin SA, Haren MT, Taylor AW, Wittert GA, . Members of the Florey Adelaide Male Ageing Study Inverse associations between muscle mass, strength, and the metabolic syndrome. Metabolism: Clinical and Experimental 2009, 58:1013-1022. Members of the Florey Adelaide Male Ageing Study.
6. Kuk JL, Kilpatrick K, Davidson LE, Hudson R, Ross R. Whole-body skeletal muscle mass is not related to glucose tolerance or insulin sensitivity in overweight and obese men and women. Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquee, Nutrition et Metabolisme 2008, 33:769-774. 10.1139/H08-060, 18641721.
7. Schutte JE, Longhurst JC, Gaffney FA, Bastian BC, Blomqvist CG. Total plasma creatinine: an accurate measure of total striated muscle mass. Journal of Applied Physiology: Respiratory, Environmental and Exercise Physiology 1981, 51:762-766.
8. Proctor DN, O'Brien PC, Atkinson EJ, Nair KS. Comparison of techniques to estimate total body skeletal muscle mass in people of different age groups. American Journal of Physiology 1999, 277:t-95.
9. Yonemura K, Takahira R, Yonekawa O, Wada N, Hishida A. The diagnostic value of serum concentrations of 2-(alpha-mannopyranosyl)-L-tryptophan for normal renal function. Kidney International 2004, 65:1395-1399. 10.1111/j.1523-1755.2004.00521.x, 15086480.
10. Harita N, Hayashi T, Sato KK, Nakamura Y, Yoneda T, Endo G, et al. Lower serum creatinine is a new risk factor of type 2 diabetes: the Kansai healthcare study. Diabetes Care 2009, 32:424-426. 10.2337/dc08-1265, 2646021, 19074997.
11. Tomaszewski M, Charchar FJ, Maric C, McClure J, Crawford L, Grzeszczak W, et al. Glomerular hyperfiltration: a new marker of metabolic risk. Kidney International 2007, 71:816-821. 10.1038/sj.ki.5002160, 17332732.
12. Lorenzo C, Nath SD, Hanley AJ, Abboud HE, Gelfond JA, Haffner SM. Risk of type 2 diabetes among individuals with high and low glomerular filtration rates. Diabetologia 2009, 52:1290-1297. 10.1007/s00125-009-1361-4, 19367385.
13. Chagnac A, Weinstein T, Korzets A, Ramadan E, Hirsch J, Gafter U. Glomerular hemodynamics in severe obesity. American Journal of Physiology - Renal Physiology 2000, 278:F817-F822.
14. Griffin KA, Kramer H, Bidani AK. Adverse renal consequences of obesity. American Journal of Physiology - Renal Physiology 2008, 294:F685-F696. 10.1152/ajprenal.00324.2007, 18234955.
15. Hjelmesaeth J, Hofso D, Aasheim ET, Jenssen T, Moan J, Hager H, et al. Parathyroid hormone, but not vitamin D, is associated with the metabolic syndrome in morbidly obese women and men: a cross-sectional study. Cardiovascular Diabetology 2009, diabetol..: 8, 2644287, 19187564.
16. Levey AS, Coresh J, Greene T, Marsh J, Stevens LA, Kusek JW, et al. Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clinical Chemistry 2007, 53:766-772. 10.1373/clinchem.2006.077180, 17332152.
17. World Medical Association declaration of Helsinki Recommendations guiding physicians in biomedical research involving human subjects. JAMA 1997, 277:925-926. 10.1001/jama.277.11.925, 9062334, World Medical Association declaration of Helsinki.
18. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2008, 31(Suppl-60). American Diabetes Association.
19. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419. 10.1007/BF00280883, 3899825.
20. Muniyappa R, Lee S, Chen H, Quon MJ. Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. American Journal of Physiology - Endocrinology and Metabolism 2008, 294:E15-E26. 10.1152/ajpendo.00645.2007, 17957034.
21. Janmahasatian S, Duffull SB, Ash S, Ward LC, Byrne NM, Green B. Quantification of lean bodyweight. Clinical Pharmacokinetics 2005, 44:1051-1065. 10.2165/00003088-200544100-00004, 16176118.
22. Demirovic JA, Pai AB, Pai MP. Estimation of creatinine clearance in morbidly obese patients. American Journal of Health-System Pharmacy 2009, 66:642-648. 10.2146/ajhp080200, 19299371.
23. de Jong PE, Curhan GC. Screening, monitoring, and treatment of albuminuria: Public health perspectives. Journal of the American Society of Nephrology 2006, 17:2120-2126. 10.1681/ASN.2006010097, 16825331.
24. Kurtze N, Rangul V, Hustvedt BE, Flanders WD. Reliability and validity of self-reported physical activity in the Nord-Trondelag Health Study (HUNT 2). European Journal of Epidemiology 2007, 22:379-387. 10.1007/s10654-007-9110-9, 17356925.
25. Wood SN. Generalized Additive Models: An Introduction with R 2006, Boca Raton, FL: Chapman & Hall/CRC.
26. Muggeo VM. Estimating regression models with unknown break-points. Statistics in Medicine 2003, 22:3055-3071. 10.1002/sim.1545, 12973787.
27. Kao WH, Folsom AR, Nieto FJ, Mo JP, Watson RL, Brancati FL. Serum and dietary magnesium and the risk for type 2 diabetes mellitus: the Atherosclerosis Risk in Communities Study. Archives of Internal Medicine 1999, 159:2151-2159. 10.1001/archinte.159.18.2151, 10527292.
28. Mykkanen L, Haffner SM, Kuusisto J, Pyorala K, Laakso M. Microalbuminuria precedes the development of NIDDM. Diabetes 1994, 43:552-557. 10.2337/diabetes.43.4.552, 8138060.
29. Wang Z, Hoy WE. Albuminuria as a marker of the risk of developing type 2 diabetes in non-diabetic Aboriginal Australians. International Journal of Epidemiology 2006, 35:1331-1335. 10.1093/ije/dyl115, 16782970.
30. R Development Core Team R: A Language and Environment for Statistical Computing 2008, Vienna: R Foundation for Statistical Computing, R Development Core Team.
31. Nelson RG, Bennett PH, Beck GJ, Tan M, Knowler WC, Mitch WE, et al. Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus. Diabetic Renal Disease Study Group. New England Journal of Medicine 1996, 335:1636-1642.
32. Jin Y, Moriya T, Tanaka K, Matsubara M, Fujita Y. Glomerular hyperfiltration in non-proteinuric and non-hypertensive Japanese type 2 diabetic patients. Diabetes Research and Clinical Practice 2006, 71:264-271. 10.1016/j.diabres.2005.06.014, 16125272.
33. Hofso D, Jenssen T, Hager H, Roislien J, Hjelmesaeth J. Fasting plasma glucose in the screening for type 2 diabetes in morbidly obese subjects. Obes Surg 2010, 20:302-307. 10.1007/s11695-009-0022-5, 19949889.
34. Volpi E, Nazemi R, Fujita S. Muscle tissue changes with aging. Current Opinion in Clinical Nutrition & Metabolic Care 2004, 7:405-410.
35. Biomarkers Definitions Working Group Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clinical Pharmacology and Therapeutics 2001, 69:89-95. 10.1067/mcp.2001.113989, 11240971, Biomarkers Definitions Working Group.